1. Home
  2. SAVA vs RVSB Comparison

SAVA vs RVSB Comparison

Compare SAVA & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.13

Market Cap

96.1M

Sector

Health Care

ML Signal

HOLD

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.38

Market Cap

105.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAVA
RVSB
Founded
1998
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
96.1M
105.2M
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
SAVA
RVSB
Price
$2.13
$5.38
Analyst Decision
Buy
Buy
Analyst Count
2
1
Target Price
$5.00
$7.00
AVG Volume (30 Days)
772.9K
53.2K
Earning Date
03-02-2026
01-27-2026
Dividend Yield
N/A
1.48%
EPS Growth
N/A
516.16
EPS
N/A
0.23
Revenue
N/A
$53,476,000.00
Revenue This Year
N/A
$11.67
Revenue Next Year
N/A
$9.82
P/E Ratio
N/A
$23.57
Revenue Growth
N/A
15.88
52 Week Low
$1.15
$4.74
52 Week High
$4.98
$6.59

Technical Indicators

Market Signals
Indicator
SAVA
RVSB
Relative Strength Index (RSI) 47.99 57.55
Support Level $2.04 $5.25
Resistance Level $2.22 $5.46
Average True Range (ATR) 0.11 0.14
MACD 0.03 0.01
Stochastic Oscillator 62.86 65.22

Price Performance

Historical Comparison
SAVA
RVSB

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

Share on Social Networks: